Diagnosis

Syphilis

Infectious disease caused by the spirochete Treponema pallidum.

Etiology

Cause [ckb]

Pathophysiology [qzt][ckb]

  1. Transmitted by:

    • Intimate contact with infectious lesions (most common)

    • Blood transfusion

    • Transplacentally from an infected mother to fetus in utero (congenital)

  2. Treponema pallidum rapidly penetrates intact mucous membranes within a few hours and enters the lymphatics and blood to produce systemic infection.

  3. If untreated, it progresses through 4 stages: primary, secondary, latent, and tertiary.

    1. Primary syphilis:

      • Development of a highly infectious painless chancre at the site of transmission

      • Localization: Genitals, digits, nipples, tonsils, and oral mucosa

      • Chancre consists of mononuclear leukocytes, macrophages, and lymphocytes

      • Healing occurs within 3-12 weeks with considerable residual fibrosis

      • Resolve without treatment and 25% may go to secondary phase if untreated

    2. Secondary syphilis: 4-10 weeks after the appearance of the primary lesion

      • The spirochetes multiply and spread throughout the body

      • Systemic manifestations: Headache, malaise, fever, myalgia, arthralgia, lymphadenopathy, pharyngitis, hepatosplenomegaly, alopecia, and maculopapular rash involving the palms and soles

      • Resolve without treatment and the patient may enter latent phase if untreated

    3. Latent syphilis: secondary syphilis have resolved, but patients remain seroreactive

      • 1/3 of untreated latent syphilis patients go on to develop tertiary syphilis

    4. Tertiary syphilis (rare): slow inflammatory damage over months to years

      • Gummatous syphilis:

        • Necrotizing granulomas (gummas) in the liver, bones, testes or any organ

      • Cardiovascular syphilis (80-85%)

        • Aortitis

        • Aneurysm in the ascending aorta due to chronic inflammatory destruction

        • Aortic valve insufficiency may result

      • Neurosyphilis (5-10%)

        • CSF: high protein, low glucose, high lymphocytes, positive syphilis serology

        • Damage to the blood vessels of the meninges, brain, and spinal cord

        • Parenchymal neurosyphilis: Meningitis, hemiplegia, stroke, aphasia, seizures, spinal neuroarthropathy, tabes dorsalis (demyelination of dorsal medulla spinalis)

        • Paresis, areflexia and impaired vibration/proprioceptive/pain/temperature sensation leading to a wide-based gait

    5. Congenital syphilis (infection of the fetus in utero):

      • A high rate of spontaneous abortion and stillbirth

      • Widespread condylomata lata and rash, and mucopurulent rhinitis

      • Bone/teeth deformities (saddle nose, saber shins, Cluttons joints, Hutchinsons teeth, mulberry molars), general paresis, deafness and blindness

Complications [ckb]

Epidemiology

Incidence per 100.000 [vsr][69w][qzt][9fa]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Agitation, Alopecia, Anorexia, Aphasia, Areflexia, Arthralgia, Arthritis, Ataxia, Blindness, Dementia, Diastolic murmur, Epistaxis, Fatigue, Fever, Headache, Hearing loss, Hepatomegaly, Lymphadenopathy, Malaise, Myalgia, Nausea, Neck stiffness, Paresis, Paresthesia, Photophobia, Psychosis, Rhinorrhea, Splenomegaly, Urinary incontinence, Weakness

Clinical findings

Chorioretinitis, Glomerulonephritis, Hemoglobinuria, Hepatitis, Hydrops, Iritis, Keratitis, Optic neuritis, Pericardial effusion, Periostitis, Pharyngitis, Proctitis, Renal failure, Thrombocytopenia

Anamneses

None listed.

Localized findings

Pain
Radiates
Bone (skeleton)JointsMuscles
Onset
Gradual (days)
Pattern
Constant
Severity
Mild (1-3)Moderate (4-7)
Rash
Radiates
CaputCollumThoraxAbdomenGenitalArmBackLower body
Distribution
GeneralizedMultipleSymmetric
Lesion type
AlopeciaCondylomataMaculePapulePustule
Lesion configuration
Annular
Lesion surface
Desquamation
Color
BrownRed
Rash
Radiates
Cavum oris (inside mouth)HandGenital
Distribution
SingleMultipleLocalized
Lesion type
Ulcer
Color
RedBrown

Approach

Treatment

Penicillin is the preferred bacteriocidal antibiotic for all stages of syphilis [ckb]

  1. Primary, secondary, and early latent syphilis: Single dose Penicillin G 2.4 million units

  2. Tertiary/late latent syphilis: Penicillin G 2.4 million units intramuscular (for 3 weeks)

  3. Neurosyphilis: Penicillin G 3 to 4 million units IV every 4 hours daily for 10 to 14 days

  4. Alternatives:

    • Doxycycline 100 mg orally (PO) twice daily for 14 days

    • Ceftriaxone 1 to 2 gm IM or intravenously (IV) daily for 10 to 14 days

    • Tetracycline 100 mg PO 4 times daily for 14 days

  5. Congenital Syphilis:

    Penicillin G 50,000 units/kg body weight/dose IV every 12 hours during the first 7 days after birth, then every 8 hours for 10 days

Differential diagnoses

Behcet's disease, Brain tumor, Candidiasis, Chancroid, Chlamydia, Contact dermatitis, Dementia, Eczema, Encephalitis, Erythema multiforme, Fungal infection, Granuloma inguinale, Heart failure, Herpes simplex, Herpes zoster, HIV, Human papillomavirus, Lymphogranuloma venereum, Lymphoma, Meningitis, Mononucleosis, Pityriasis rosea, Psychosis, Rocky mountain spotted fever, Sarcoidosis, Stroke, Urinary tract infection, Uveitis, Yaws


References

[1] Tudor ME, Al Aboud AM, Leslie SW, et al. Syphilis. [Updated 2024 Aug 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534780/

[2] Kojima N, Klausner JD. An Update on the Global Epidemiology of Syphilis. Curr Epidemiol Rep. 2018 Mar;5(1):24-38.

[3] Rates of reported cases of syphilis in the United States in 2023, by age and gender. John Elflein: https://www.statista.com/statistics/622816/syphilis-rate-in-the-us-by-age-and-gender/

[4] Gregory ECW, Ely DM. Trends and Characteristics in Maternal Syphilis Rates During Pregnancy: United States, 2016-2022. NCHS Data Brief. 2024 Feb;(496):1-8.

[5] Yu W, You X, Luo W. Global, regional, and national burden of syphilis, 1990-2021 and predictions by Bayesian age-period-cohort analysis: a systematic analysis for the global burden of disease study 2021. Front Med (Lausanne). 2024 Aug 15;11:1448841.

[6] http://emedicine.medscape.com/article/157325 (2014-01-21); [Medscape]

[7] http://emedicine.medscape.com/article/229461 (2014-01-02); [Medscape]

Scroll to top